Synpolydactyly (SPD) is a rare malformation of the distal limbs known to be caused by mutations in HOXD13. We have previously described a complex form of SPD associated with synostoses in three members of a Belgian family, which co-segregates with a t(12;22)(p11.2;q13.3) chromosomal translocation. The chromosome 12 breakpoint of this translocation maps to 12p11.2 between markers D12S1034 and D12S1596. Here we show that a mutation in the HOXD13 gene is not responsible for the phenotype, and present a physical map of the region around the 12p11.2 breakpoint. Starting from D12S1034 and D12S1596, we have established a contig approximately 1.5 Mb in length, containing 13 YAC clones, 16 BAC clones, and 11 cosmid clones. FISH analysis shows that cosmid LL12NCO1-149H4 maps across the breakpoint, and Southern blot experiments using fragments of this cosmid as probes identify a rearranged BamHI fragment in the patients carrying the translocation. A search for expressed sequences within the contig have so far revealed one CpG island, seven anonymous ESTs and three previously characterised genes, DAD-R, KRAG and HT2I, all of which were found not to be directly disrupted by the translocation. The gene represented by EST R72964 was found to be disrupted by the translocation. These findings lay the groundwork for further efforts to characterise a gene critical for normal distal limb development that is perturbed by this translocation.
Introduction
Synpolydactyly (SPD, OMIM No. 186000) is a rare dominantly inherited malformation of the distal limbs in which there is a combination of syndactyly (webbing of digits) and polydactyly (supernumerary digits). Typically, there is a syndactyly between the third and fourth fingers and between the fourth and fifth toes, with partial or complete digit duplication in the synpolydactyly web. In most cases this condition is caused by mutations in the HOXD13 gene, which is located on chromosome 2q31. Classical SPD has been shown to be due to different sized expansions of an imperfect trinucleotide repeat sequence encoding a 15-residue N-terminal polyalanine tract in HOXD13. [1] [2] [3] An atypical form of SPD, associated with a novel foot phenotype, has been found in two families with two differing intragenic deletions in HOXD13. 4 We recently described a Belgian family ( Figure 1 ) in which three individuals have a complex type of SPD associated with metacarpal and metatarsal synostoses. 5, 6 The phenotype in these patients is distinct from that in any previously reported case of SPD and appears to represent a novel dominantly inherited limb malformation. Interestingly, this malformation is not accompanied by an expansion of the HOXD13 polyalanine tract, and seems to co-segregate in the family with an apparently balanced translocation t(12;22) (p11.2;q13.3). 7 This co-segregation suggests that perturbation of a gene (or genes) located at 12p11.2 and/or 22q13.3 may underlie this unique form of SPD. Although no 'SPD gene' has previously been assigned to chromosome 12p11 or 22q13, a locus for dominantly inherited hypertension combined with the distal limb malformation brachydactyly has been shown to map to chromosome 12p11. 8 We have previously mapped the chromosome 12p11 breakpoint in our patients to the interval between markers D12S1596 and D12S1034, and the chromosome 22q13 breakpoint to the interval between markers D22S158 and N73F4. 7 Interestingly, the interval between D12S1596 and D12S1034, which is no larger than 1.7 Mb, maps to the region containing the hypertension/brachydactyly locus. This finding thus raised the intriguing possibility that different mutations affecting the same gene on 12p11 might give rise to two distinct distal limb malformationsbrachydactyly and complex SPD.
In our current communication, we have formally excluded the possibility that a mutation elsewhere in HOXD13 might nevertheless be responsible for the SPD-like phenotype by analysing the entire coding sequence in one affected family member. No mutations were found. We therefore directed our attention to the 12p11 breakpoint, using markers D12S1596 and D12S1034 as starting points for a chromosome walk. Here we describe a contig containing 12 YACs and 16 BACs spanning 1.5 Mb around the chromosome 12 translocation breakpoint region. Mapping of sequence tagged sites (STSs) and sequence tag connectors (STCs) together with restriction digests have allowed us to establish a long range physical map of the region. STCs derived from the ends of the appropriate BACs have been used to isolate cosmids for FISH studies, one of which (LL12NCO1-149H4) proved to span the chromosome 12p11 breakpoint. To date, three previously reported genes and seven anonymous ESTs corresponding to four cDNAs have been identified and positioned within the contig. The gene represented by one of the ESTs was subsequently found to be disrupted by the translocation.
Materials and methods

Subjects
A pedigree of the family is shown in Figure 1 . The three affected family members, a father (II.2) and his two daughters (III.1 and III.2), all have a complex type of SPD associated with metacarpal and metatarsal synostoses, as reported previously. 5, 6 14 After sequence analysis, primer pairs were designed using the computer program OLIGO. 15 Primers are listed in Table 1 .
Results
HOXD13 mutation analysis
Using PCR amplification and direct sequencing, we have previously shown that the imperfect trinucleotide repeat in exon 1 of HOXD13, which encodes the 15-residue polyalanine tract expanded in classical SPD, was normal in length in individual II.2. 7 In one of his alleles, however, alanine 12 of the tract was encoded by GCG rather than by GCA. This base change represents a single nucleotide polymorphism, resulting in a silent mutation, however, since the same finding has previously been reported in 5/20 normal and 8/20 expanded alleles, 3 and was also seen in the patient's unaffected mother (I.2). Here, we investigated whether some other mutation in HOXD13 could be responsible for the novel complex type of SPD present in our patients. Using primer pairs designed to amplify the whole coding region of HOXD13, we identified no such mutations in individual II.2.
Construction of a 1.5-Mb YAC contig and physical map
In a previous study, 7 we established that the 12p11.2 breakpoint in our patients was located between markers D12S1034 and D12S1596. These markers both reside within YAC 774E2, which is 1.7 Mb in length. By FISH analysis, which was performed essentially as described previously, 16, 17 this YAC was shown to map across the breakpoint. (Table 2) . Restriction maps of each of these YACs were aligned and a consensus restriction map of the region established, as illustrated in Figure 2 . Interestingly, YAC 368D4 included both D12S1034 and D12S1596, thereby narrowing the region containing the breakpoint to the size of this YAC (350 kb). Several YACs isolated with markers D12S1411 and EMBL z38802 (which are both known to lie centromeric to the breakpoint on chromosome 12p) were also found to overlap with YACs containing D12S1034. An additional 5 YACs (Table 2a) could thus be integrated into our contig so that it eventually comprised 13 YACs spanning approximately 1.5 Mb of DNA.
Construction of a BAC and cosmid contig
To pinpoint the breakpoint region further, we constructed a BAC contig anchored on D12S1034 and D12S1596. By screening the BAC library with these two markers, we obtained seven D12S1596-anchored BACs and three D12S1034-anchored BACs (Table 2b ). Restriction maps of each of these BACs were constructed and aligned into two separate contigs, centered on D12S1034 and D12S1596, respectively. The chromosomal orientation of these contigs was determined by FISH analysis using cosmids mapping to isolated BAC ends. Thus, LL12NCO1-247C2, containing PD56 (derived from BAC 549C24) mapped telomeric to the breakpoint (positive signal on the normal chromosome 12 and the der (22)), whereas LL12NCO1-71E7, containing PD64 (derived from BAC 570H2) mapped centromeric to the breakpoint (positive signal on the normal chromosome 12 and the der(12); results not shown).
Since the two BAC contigs anchoring at D12S1034 and D12S1596 did not overlap, the BAC library screen was repeated, using probes PD56 and PD64. Six additional BACs (Table 2b) were isolated, allowing the two contigs to be merged ( Figure 3 ). In addition, BAC 264F23 was found to span the breakpoint on FISH analysis (positive signal on the normal chromosome 12, the der(12) and the der(22); results not shown).
Based on STS/STC-content mapping, 11 cosmids (Table 2c ), isolated to position the various BAC STCs, could also be grouped into a single contig. The positions of these cosmids relative to the t(12;22) breakpoint were independently confirmed by STC-content mapping of the newly generated STCs as well as by FISH.
Physical mapping of STSs, STCs, ESTs and known genes
By sequencing the ends of the isolated BACs, we generated multiple novel STCs which were subsequently integrated into the contig described above. STCs were also generated from the ends of cosmids which had been isolated to position the BAC ends more precisely relative to the translocation breakpoints, and in a few cases from the ends of YACs. A total of 23 STCs were generated in this way. An additional STC (PD81) was derived from the left end of YAC 170A5. This STC was isolated as a suitable starting point for a sequencewalking approach aimed at isolating CpG island sequences, as it maps close to a cluster of sites recognised by rare-cutter restriction enzymes, which is generally indicative of a CpG island. 18 All sequence data obtained were analysed for the presence of repeats and transcribed sequences. This approach revealed that the contig contained exons 1 and 5 of KRAG (Kirsten-ras associated gene -GenBank accession no. X89105); and STS marker D12S1411, corresponding to the 3'UTR of HT2I (encoding the type 2 inositol, 1,4,5-triphosphate receptor (IP 3 R) -GenBank accession no. D26350). Our previous FISH studies had shown that D12S1411 maps centromeric to the breakpoint. To determine the orientation of the HT2I gene relative to the breakpoint, an EST containing HT2I sequences upstream of the 3'UTR (HT2I-int, position 3993-4092, Figure 2 ) was mapped within the contig. Cosmids isolated using probes derived from the 3' and 5' ends of the gene all mapped centromeric to the breakpoint on FISH analysis, indicating that the entire HT2I gene lies centromeric to the breakpoint (data not shown). Finally, the DAD1-homolog DAD-R was recently isolated and mapped to 12p12.1-11.2 by Kuittinen et al, following a positional cloning effort focusing on recurrent chromosome 12 aberrations (manuscript in preparation). The use of DAD-R specific primers initially allowed us to position this gene within YAC 292C10 (by STS-content mapping approach). Subsequent Southern blotting experiments showed that the gene was situated within a SalI-BssHII restriction fragment of approximately 10 kb, located at the telomeric part of our contig ( Figure 2 ). The contig also contains several non-overlapping ESTs which do not correspond to any known genes (AA190175, isolated using STC PD120; T48235, isolated using STC PD122; and R72964, isolated using STC PD108), as well as the overlapping ESTs AA701549, AA380212, AA782961, and AA532445 (isolated using STC PD168). Based on northern blot analysis of multiple adult human tissues, AA190175 appears to be exclusively expressed in testis as a 2.4 kb transcript ( Figure 3B ), whereas T48235 is widely expressed as a 2.2 kb transcript, with particularly high expression levels in prostate and placenta ( Figure 3C ). R72964 is homologous to a putative regulator of cell growth and differentiation (SwissProt accession no. B44478). It is widely expressed as a transcript of 6.2 kb, with particularly high expression levels in skeletal muscle, although it is apparently not expressed at all in peripheral blood leukocytes ( Figure 3A) . A 2.2 kb transcript (possibly resulting from alternative splicing) is also expressed exclusively in testis. The remaining four overlapping ESTs are exclusively expressed in testis as a 1.8 kb transcript ( Figure 3D ). ND  ND  5H3  180  D12S1034  PD71  AJ012001  PD70  AJ012002  PD64  570H2  210  D12S1034  PD64  AJ011998  ND  PD64  526G26  125  D12S1596  PD52  AJ011994  PD53  AJ011995  156L15  80  D12S1596  ND  ND  542J7  160  D12S1596  PD55  AJ011996  ND  PD56  549C24  120  D12S1596  PD57  AJ012450  PD56  AJ011997  PD56  312G2  180  D12S1596  ND  ND  567H24  150  D12S1596  ND  ND  438C7  110  D12S1596  PD72  AJ012451  PD73  AJ012453  479I21  125  PD56  PD92  AJ012003  ND  177H19  50  PD56  ND  ND  554E4  130  PD56  ND  ND  520I17  180  PD56  ND  ND  241P15  115  PD64  PD97  AJ012004  ND  264F23  115  PD64  ND ND  ND  c135F7  below  D12S1034  ND  ND  c247C2  above  PD56  ND  ND  c71E7  below  PD64  PD109  AJ012259  PD108  AJ012258  c139H2  ND  PD64  PD122  AJ012262  ND  c48H9  above  PD81  PD100  AJ012257  ND  c93A1  ND  PD108  PD120  ND  c202B11  below  PD108  ND  ND  c219E2  below  PD109  PD119  AJ012261  PD118  AJ012260  c149H4  across  PD119  ND  ND  c50G3  ND  PD100  PD168  requested . Polymorphic restriction sites are marked with an asterisk. DNA intervals predicted to contain additional restriction sites for some of these enzymes are indicated by arrows. DNA markers, shown in green boxes are assigned to particular DNA intervals as indicated by arrows. Primer sets for these markers were either designed as described in Materials and methods (Table 1) Figure 4 , signals on the normal chromosome 12, the der(12), and the der(22) were clearly visible, confirming that this cosmid spans the breakpoint. We therefore constructed several subclones of LL12NCO1-149H4 for use in Southern blot experiments. Probe 149H4-B5-SB, derived from a 11 kb BamHI subclone (p149H4-B5) of L12NCO1-149H4, hybridised to a 2.6 kb BamHI fragment in digested genomic DNA from patient II.2 which was not present in similarly digested genomic DNA from two control individuals (Figure 4) . Probe 149H4-B7-SB also detected rearranged BamHI, EcoRI, HindIII and PstI fragments in digests of genomic DNA from patient II.2 (results not shown). On the basis of this data, we predict that the breakpoint lies close to the first HindIII site shown in Figure 4 . Since the length of the rearranged BamHI fragment was only 2.6 kb and since probe 149H4-B5-SB did not detect a rearranged HindIII fragment, we conclude that the breakpoint must lie immediately adjacent to the first HindIII site in p149H4-B5, as was confirmed by Southern blot analysis with probe 149H4-B7-SB.
Isolation of a cosmid spanning the breakpoint
Isolation of the CpG island
In order to isolate sequences mapping near the CpG island located in the immediate vicinity of the breakpoint, three flanking cosmids were analysed for the presence of a NotI restriction site. Cosmids LL12NCO1-50G3, LL12NCO1-71E7 and LL12NCO1-219E2 were digested with BamHI, BamHI/ NotI, EcoRI, EcoRI/NotI, XbaI, and XbaI/NotI and analysed on a 0.8% agarose gel. Only in cosmid LL12NCO1-50G3, which overlaps with the breakpoint-spanning cosmid LL12NCO1-149H4 (Figure 3) , was a NotI restriction site identified. Subsequent sequencing around this NotI site yielded genomic sequences showing extensive homology to ESTs AA308212, N30918 and N36628, which all reside within the PD168 cDNA contig, as well as to EST R72964, belonging to the PD108 contig.
Discussion
Mutations in the HOXD13 gene cause both classical SPD [1] [2] [3] and an atypical form of SPD. 4 No mutations were identified in the HOXD13 gene of affected individual II.2, supporting (Figure 4) .
Of the seven ESTs we have thus far identified within the contig, EST AA190175 and the overlapping ESTs, AA701549, AA308212, AA782961 and AA532445 appear to be expressed in testis only, making them unlikely candidates for the phenotype observed in our patients. Both EST T48235 and EST R72964 are widely expressed. Whilst the 5' end of T48235 lies close to the breakpoint, its 3' end is more distant, and the corresponding gene is unlikely to be disrupted by the translocation, although a position effect cannot be ruled out. Interestingly, extended genomic sequencing of the NotIcontaining CpG island led to the identification of a downstream (but not terminal!) exon contained within the composite cDNA contig anchoring to R72964. Since this NotI site and the flanking exon are present in cosmid LL12NCO1-50G3 [situated telomeric/distal (ie to the left in Figure 3 ) to the breakpoint] but absent in cosmid LL12NCO1-149H4 (containing the breakpoint), this R72964 exon is situated on 'the other side' of the breakpoint. This implies that the gene represented by EST R72964 is indeed disrupted by the translocation. Further experiments aiming at the elucidation of the functional consequences of this disruption are currently under way. Northern blot analysis of patient-derived RNA has so far not revealed any aberrant-sized transcripts. Northern blot analysis of a commercially available northern blot (Clontech) containing four foetal tissues (liver, kidney, lung, and brain) confirmed expression of R72964 (as a single, 6.2 kb transcript) during foetal development (results not shown).
Our contig also contains three previously reported genes, DAD-R, KRAG, and HT2I. The one-exon gene DAD-R was recently isolated by Kuittinen et al (personal communication, 1999) . Its homolog DAD1 was first isolated in 1993 by Nakashima and co-workers as a defender against apoptotic cell death, 19 and was subsequently shown to be a subunit of oligosaccharyltransferase. 20 Interestingly, some heterozygous Dad1-deficient mice have been reported to display soft-tissue syndactyly, making its homolog DAD-R a likely positional as well as functional candidate gene. 21 KRAG consists of five exons spanning about 20 kb of genomic DNA and encodes a protein which is probably involved in the regulation of cell proliferation. 22 HT2I encodes the type 2 IP 3 R, which plays an important role in signal transduction. 23 All three of these genes, however, lie too far from the breakpoint to be directly disrupted by the translocation, although a positional effect cannot be entirely ruled out. As human IP 3 R is involved in signal transduction and regulation of intracellular Ca 2 + levels, HT2I is nevertheless an excellent positional as well as functional candidate gene for the dominantly inherited hypertension syndrome mapped to chromosome 12p11 by Schuster et al. 8 Lack of the HT2I receptor would reduce endothelial release of intracellular Ca 2 + , which in turn would reduce prostacyclin release, thus producing vasoconstriction and elevation of the blood pressure. In the family described by Schuster et al, the hypertension co-segregated completely with the form of brachydactyly, suggesting that the two traits were caused either by two different mutations in two closely situated genes or by one mutation in a single pleiotropic gene. A mutation in HT2I might also product brachydactyly, as the inositol-triphosphate/Ca 2 + signalling pathway affects cell growth and proliferation, although it is unclear why the effects of such a mutation should be confined to the developing distal limb. In summary, we have shown that the complex SPD in our patients is not part of the phenotypic spectrum caused by HOXD13 mutations. To isolate the gene responsible, we have constructed a long range physical map of YACs, BACs and cosmids encompassing the 12p11.2 translocation breakpoint region in this family. This map should also aid in a structured approach to sequencing the region in question. Since EST R72964 seems to be directly involved in this translocation, our research is currently directed in further elucidating the functional consequences of this disruption.
